UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 2 | February 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 5
May-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2405011


Registration ID:
537321

Page Number

a78-a86

Share This Article


Jetir RMS

Title

A Review on Intranasal treatment for Epilepsy

Abstract

One of the most prevalent neurological conditions affecting the brain, epilepsy affects around 50 million people globally, with 90% of cases occurring in poorer nations. It is a general condition that impacts people of all ages. Infections in the brain, stroke, tumors, and elevated temperature are among the genetic variables that can Reasons for epilepsy. About 125,000 new instances of epilepsy are reported year; of these, 30% involve people under the age of 18 years old at diagnosis. In India, 3-11/1000 and 0.2-0.6/1000 are the observed prevalence and incidence, respectively. The antiepileptic medications that are currently on the market are usually taken orally, and as a result, they frequently show a high systemic distribution into tissues that are not their intended target, resulting in peripheral effects and restricted brain absorption.To enhance the effectiveness and tolerance of antiepileptic medication therapy, substitute Research has been done on administration tactics. The olfactory epithelium is located on the nasal cavity’s roof. Is said to directly transport drugs breathed into the nose to the brain. One antiepileptic medication should typically be used to begin treatment. Typically, first-line medications include valproate, oxcarbazepine, carbamazepine, phenytoin, and phenobarbitone. The epidemiology, aetiology, pathophysiology, epilepsy categorization, symptoms, and epilepsy diagnosis and treatment.

Key Words

Epilepsy , Seizures, Intranasal route, Antiepileptic drug

Cite This Article

"A Review on Intranasal treatment for Epilepsy ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 5, page no.a78-a86, May-2024, Available :http://www.jetir.org/papers/JETIR2405011.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Review on Intranasal treatment for Epilepsy ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 5, page no. ppa78-a86, May-2024, Available at : http://www.jetir.org/papers/JETIR2405011.pdf

Publication Details

Published Paper ID: JETIR2405011
Registration ID: 537321
Published In: Volume 11 | Issue 5 | Year May-2024
DOI (Digital Object Identifier):
Page No: a78-a86
Country: latur maharashtra, maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000215

Print This Page

Current Call For Paper

Jetir RMS